Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 18.

Journal Article

Besse, Benjamin, Drilon, Alexander E., Solomon, Benjamin J., Subbiah, Vivek, Tan, Daniel Shao-Weng, Park, Keunchil, De Braud, Filippo G., Alonso, Guzman, Wolf, Juergen, Soldatenkova, Victoria, Lin, Aimee K., French, Pearl Plernjit, Goto, Koichi and Gautschi, Oliver (2021). Updated overall efficacy and safety of selpercatinib in patients (pts) with RET fusion plus non-small cell lung cancer (NSCLC). J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

De Castro, Gilberto, Jr., Tan, Daniel Shao-Weng, Crino, Lucio, Wu, Yi Long, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut, Orlov, Sergey, Cortinovis, Diego, Yu, Chong-Jen, Hochmair, Maximilian, Cortot, Alexis, Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario Garcia, Branle, Fabrice, Sen, Paramita, Mcculloch, Tracey and Soria, Jean-Charles (2017). First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK plus ) NSCLC: A Randomized, Phase 3 Study (ASCEND-4). J. Thorac. Oncol., 12 (1). S. S7 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Drilon, Alexander E., Gautschi, Oliver, Besse, Benjamin, Subbiah, Vivek, Tan, Daniel Shao-Weng, Park, Keunchil, De Braud, Filippo G., Alonso, Guzman, Wolf, Juergen, Soldatenkova, Victoria, French, Pearl Plernjit, Lin, Aimee K., Goto, Koichi and Solomon, Benjamin J. (2021). Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion plus non-small-cell lung cancer (NSCLC). J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Groen, Harry J. M., Akerley, Wallace L., Souquet, Pierre Jean, Laack, Eckart, Han, Ji-Youn, Smit, Egbert F., Mansfield, Aaron Scott, Garon, Edward B., Wolf, Juergen, Tan, Daniel Shao-Weng, Heist, Rebecca Suk, Waldron-Lynch, Maeve, Le Mouhaer, Sylvie, Nwana, Ngozi, Giovannini, Monica and Orlov, Sergey (2020). Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small-cell lung cancer (NSCLC): results from cohort 6 of the phase 2 GEOMETRY mono-1 study. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Heist, Rebecca Suk, Garon, Edward B., Tan, Daniel Shao-Weng, Groen, Harry J. M., Seto, Takashi, Smit, Egbert F., Zou, Mike R., Yang, Yiqun, Li, Ying, Chassot-Agostinho, Andrea and Wolf, Juergen (2021). Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay: Results from the GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Kempf, Emmanuelle, Penel, Nicolas, Tournigand, Christophe, Gajate, Pablo, Tan, Daniel Shao-Weng, Cassier, Philippe, Nogova, Lucia, Cathomas, Richard, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Sayehli, Cyrus, Navarro, Alejandro, Park, Se Hoon, Piciu, Ana-Maria, Bender, Sebastian, Nogai, Hendrik, Ellinghaus, Peter, Joerger, Markus and Schuler, Martin H. (2020). Phase I experience with rogaratinib in patients (pts) with urothelial carcinoma (UC) selected based on FGFR mRNA overexpression. J. Clin. Oncol., 38 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel Shao-Weng, Felip, Enriqueta, Chow, Laura Quan Man, Camidge, D. Ross, Vansteenkiste, Johan F., Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin H., Liu, Geoffrey, Santoro, Armando ORCID: 0000-0003-1709-9492, Geraldes, Margarida, Boral, Anthony, Yovine, Alejandro Javier and Shaw, Alice Tsang (2014). Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK plus ) non-small cell lung cancer (NSCLC): Results of the ASCEND-1 trial. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kim, Dong-Wan, Tan, Daniel Shao-Weng, Aix, Santiago Ponce, Sequist, Lecia V., Smit, Egbert F., Hida, Toyoaki, Yang, James Chih-Hsin, Felip, Enriqueta, Seto, Takashi, Grohe, Christian, Wolf, Juergen, Ko, Jinnie, Diallo, Mariama, Pultar, Philippe, Giovannini, Monica and Kim, Sang-We (2018). Preliminary Phase II results of a multicenter, open-label study of nazartinib (EGF816) in adult patients with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC). J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kong, Say Li, Liu, Xingliang, Tan, Swee Jin, Tai, Joyce A., Phua, Ler Yee, Poh, Huay Mei, Yeo, Trifanny, Chua, Yong Wei, Haw, Yu Xuan, Ling, Wen Huan, Ng, Raymond Chee Hui, Tan, Tira J., Loh, Kiley Wei Jen, Tan, Daniel Shao-Weng, Ng, Quan Sing, Ang, Mei Kim, Toh, Chee Keong, Lee, Yi Fang, Lim, Chwee Teck, Lim, Tony Kiat Hon, Hillmer, Axel M., Yap, Yoon Sim and Lim, Wan-Teck ORCID: 0000-0002-4655-0206 (2021). Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer. Front. Oncol., 11. LAUSANNE: FRONTIERS MEDIA SA. ISSN 2234-943X

Tan, Daniel Shao-Weng, Lee, Dae Ho, Soo, Ross, Michels, Sebastian, Barlesi, Fabrice, Sangha, Randeep, Le Gac, Fabienne, Pultar, Philippe, Glaser, Sabine, Cui, Xiaoming, Akimov, Mikhail and Felipe, Enriqueta (2017). Phase lb Results from a Study of Capmatinib (INC280)+EGF816 in Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC). J. Thorac. Oncol., 12 (1). S. S1264 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Tan, Daniel Shao-Weng, Leighl, Natasha B., Yang, James Chih-Hsin, Riely, Gregory J., Sequist, Lecia, V, Toyozawa, Ryo, Wolf, Juergen, Felip, Enriqueta, Kim, Sang-We, Aix, Santiago Ponce, Smit, Egbert F., Hida, Toyoaki, Grohe, Christian, Ghebremariam, Samson, O'Sullivan-Djentuh, Leslie, Belli, Riccardo, Giovannini, Monica and Kim, Dong-Wan (2020). Nazartinib (EGF816) in patients with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC): Updated phase II results. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Tan, Daniel Shao-Weng, Shaw, Alice Tsang, Mehra, Ranee, Felip, Enriqueta, Chow, Laura Quan Man, Camidge, D. Ross, Vansteenkiste, Johan F., Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin H., Liu, Geoffrey, Santoro, Armando ORCID: 0000-0003-1709-9492, Geraides, Margarida, Boral, Anthony, Yovine, Alejandro Javier and Kim, Dong-Wan (2014). Ceritinib in Asian versus Caucasian patients (Pts) with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK plus ) NSCLC: Subgroup analysis of the ASCEND-1 trial. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Tan, Daniel Shao-Weng, Soria, Jean-Charles, De Castro, Gilberto, Jr., Wu, Yi Long, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut, Orlov, Sergey, Cortinovis, Diego, Yu, Chong-Jen, Hochmair, Maximilian, Cortot, Alexis, Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario Garcia, Branle, Fabrice, Sen, Paramita, Struebbe, Gero, Mcculloch, Tracey and Crino, Lucio (2017). PROs With Ceritinib Versus Chemotherapy in Patients With Previously Untreated ALK-rearranged Nonsquamous NSCLC (ASCEND-4). J. Thorac. Oncol., 12 (1). S. S1176 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Tan, Daniel Shao-Weng, Yang, James Chih-Hsin, Leighl, Natasha B., Riely, Gregory J., Sequist, Lecia V., Felip, Enriqueta, Seto, Takashi, Wolf, Juergen, Moody, Susan Elizabeth, Adams, Kenneth, Schmitz, Shu-Fang Hsu, Tan, Eugene Y. and Kim, Dong-Wan (2016). Updated results of a phase 1 study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T790M. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Tan, Joanna Hui Juan, Li Kong, Say, Tai, Joyce A., Poh, Huay Mei, Yao, Fei, Sia, Yee Yen, Lim, Edwin Kok Hao, Takano, Angela Maria, Tan, Daniel Shao-Weng, Javed, Asif ORCID: 0000-0002-6945-9624 and Hillmer, Axel M. (2021). Experimental and bioinformatics considerations in cancer application of single cell genomics. Comp. Struct. Biotechnol. J.., 19. S. 343 - 355. AMSTERDAM: ELSEVIER. ISSN 2001-0370

Wolf, Juergen, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Gilloteau, Isabelle, Le Mouhaer, Sylvie, Cai, Can, Chassot-Agostinho, Andrea, Reynolds, Maria, Odom, Dawn and Heist, Rebecca Suk (2021). Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the phase II GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Wolf, Juergen, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Robeva, Anna, Le Mouhaer, Sylvie, Carbini, Mariana, Chassot-Agostinho, Andrea and Heist, Rebecca Suk (2021). Capmatinib in MET exon 14-mutated, advanced NSCLC: Updated results from the GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Wolf, Juergen, Overbeck, Tobias R., Han, Ji-Youn, Hochmair, Maximilian, de Marinis, Filippo, Ohashi, Kadoaki, Smit, Egbert F., Power, Danielle, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Waldron-Lynch, Maeve, Le Mouhaer, Sylvie, Nwana, Ngozi, Giovannini, Monica and Heist, Rebecca Suk (2020). Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Mon May 16 08:01:17 2022 CEST.